IOL Advances

Lens is offering patines improved refractive, visual outcomes following cataract surgery. 

A study reviews the results, and patient satisfaction following bilateral implantation of an extended depth of focus intraocular lens.

Alcon has received FDA approval for its AcrySof IQ PanOptix Trifocal IOL, and the company is rolling out its initial commercial launch of the product.

Annual survey from ASCRS/ESCRS pinpoints trends in explantation

A diffractive trifocal IOL achieved satisfactory vision with a high rate of spectacle independence

Error in first eye can guide decisions in IOL selection for fellow eye of patients

Pearls for overcoming pitfalls related to keratometry, prediction of effective lens position, optical biometry